Yüklüyor......
MicroRNAs as Key Players in Melanoma Cell Resistance to MAPK and Immune Checkpoint Inhibitors
Advances in the use of targeted and immune therapies have revolutionized the clinical management of melanoma patients, prolonging significantly their overall and progression-free survival. However, both targeted and immune therapies suffer limitations due to genetic mutations and epigenetic modifica...
Kaydedildi:
| Asıl Yazarlar: | , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
MDPI AG
2020-06-01
|
| Seri Bilgileri: | International Journal of Molecular Sciences |
| Konular: | |
| Online Erişim: | https://www.mdpi.com/1422-0067/21/12/4544 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|